SCHEMBL30879232

SCHEMBL30879232

CS(=O)(=O)CC1CCCN(c2ccccc2N)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
USP2 O75604 1/20 0.47
GAA P10253 1/20 0.47
ADRA2C P18825 1/20 0.42
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39
PTPN1 P18031 1/20 0.38
PLA2G1B P04054 1/20 0.36
ATM Q13315 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
ABCB11 O95342 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
ADRA2A P08913 1/20 0.36
CHRM1 P11229 1/20 0.36
ADRA2B P18089 1/20 0.36
CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30921200 0.92 GAA (0.53) KEAP1MEN1KMT2AUSP2GAA
SCHEMBL30921287 0.83 GAA (0.59) KEAP1MEN1KMT2AUSP2GAA
SCHEMBL14206528 0.81 KEAP1 (0.54) KEAP1MEN1KMT2AUSP2GAA
SCHEMBL30879181 0.81 ALDH1A1 (0.55) MEN1KMT2AGAAHTTALDH1A1
SCHEMBL23043941 0.75 GAA (0.65) KEAP1MEN1KMT2AUSP2GAA
SCHEMBL3076827 0.75 GAA (0.65) KEAP1MEN1KMT2AUSP2GAA
SCHEMBL11908439 0.73 KEAP1 (0.59) KEAP1MEN1KMT2AUSP2GAA
SCHEMBL30921278 0.73 KMT2A (0.55) KMT2AKDM4EHTTALDH1A1LMNA
SCHEMBL3435118 0.72 KEAP1 (0.58) KEAP1MEN1KMT2AUSP2GAA
SCHEMBL13354910 0.72 GAA (0.56) KEAP1MEN1KMT2AUSP2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
EP-4612149-A1 PYRIDO[2,3-D]PYRIMIDIN-2-AMINE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed